MedTrace Logo

Adjunctive Use of Intra-Arterial TNK and Albumin Following Thrombectomy

NCT06113848 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2023-11-02

No results posted yet for this study

Summary

The purpose of this study is to investigate the feasibility and efficacy of intra-arterial TNK and albumin for patients with acute ischemic stroke after successful thrombectomy and whether there is a synergistic effect between TNK and albumin.

Conditions

  • Acute Ischemic Stroke

Interventions

DRUG

Intra-Arterial TNK and Albumin

The study population was divided into four groups, one of which had intra-arterial TNK and albumin.

DRUG

Intra-Arterial TNK

The study population was divided into four groups, one of which had intra-arterial TNK .

DRUG

Intra-Arterial Albumin

The study population was divided into four groups, one of which had intra-arterial albumin.

OTHER

sham

The study population was divided into four groups, one of which had no intra-arterial TNK and albumin.

Sponsors & Collaborators

  • Tianjin Huanhu Hospital

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-07
Primary Completion
2024-09-07
Completion
2024-09-07

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06113848 on ClinicalTrials.gov